ZYME Q1 2018 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$40,000-82.6% YoY

Gross Profit

-$13M-32612.5% margin

Operating Income

-$20M-50277.5% margin

Net Income

-$21M-53010.0% margin

EPS (Diluted)

$-0.83

QoQ Revenue Growth

-99.9%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$114M

Total Liabilities

$19M

Stockholders' Equity

$95M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40,000	$230,000	-82.6%
Gross Profit	-$13M	-$9M	-51.5%
Operating Income	-$20M	-$16M	-22.6%
Net Income	-$21M	-$16M	-33.1%